|
|
||||||||





*
Beijer Laboratory, Department of Genetics and Pathology, Unit of Medical Genetics, Biomedical Center, Uppsala University, Uppsala, Sweden; and
Section for Medical Inflammation Research, Sölvegaton 19, Lund University, Lund, Sweden
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
15% (4), and previous investigations clearly indicate
a role of the MHC, and in particular the MHC class II DR4 haplotype
(5, 6). DR4 is, however, a common haplotype in the general
population,, and most DR4 carriers do not develop RA, implying that
genes outside the MHC region as well as environmental factors
contribute to the pathogenesis of RA. Attempts to identify
RA-associated genes outside the MHC have been hampered by several
factors like poorly defined phenotypic criteria for disease, genetic
heterogeneity, and variable penetrance. Thus, despite large efforts, it
has been difficult to identify significant loci outside MHC in humans,
although some promising results have recently been reported (2, 7, 8). However, animal models have been shown to facilitate the
genetic analysis because they allow a better control of genetic
heterogeneity and of environmental influences. Recently, a number of
different genetic regions controlling both acute and chronic arthritis
have been identified in various rat models for RA such as
collagen-induced arthritis (CIA) (9), mycobacteria
adjuvant-induced arthritis (10), oil-induced arthritis
(11), and pristane-induced arthritis (12).
Interestingly, several of the susceptibility loci are shared between
the models, which could be explained by the fact that the DA strain was
used in all studies. Isolation of susceptibility loci in the mouse
should be of particular importance not only for the validation of the
importance of the regions in the pathogenesis of arthritis but also for
the identification of the responsible genes. CIA in the mouse is the most widely used model for studies of RA pathogenesis and for screening of new drugs for treatment of rheumatoid disease (13, 14). The disease is induced by immunization with cartilage-specific type II collagen (CII) in CFA. The most sensitive and most commonly used strain is DBA/1. Arthritis in the DBA/1 mouse develops with high a penetrance (80100%) but is also influenced by environmental factors, such as hormones, light, and stress. In fact, under certain environmental circumstances such as intermale induced stress, arthritis may develop spontaneously (15). The same factors enhance the development of CIA (16). The arthritis susceptibility is genetically controlled, and the MHC class II Aq gene has been shown to contribute (17). The product of the Aq gene presents CII-derived peptides and thereby gives the immune-specific requirements for disease development (18). Interestingly, the Aq molecule structurally and functionally related to the RA-associated DR4 (DRB1*0401/DRA) class II molecule and transgenic mice expressing DR4 are susceptible to CIA (19, 20, 21). However, just as in RA there is a significant influence by genes outside MHC, demonstrated by the fact that several Aq-expressing strains are more or less resistant to CIA (14, 22, 23, 24, 25). One such strain is the B10.Q, which develops low frequency of arthritis induced by the same immunization protocol as used for the DBA/1 mouse. To define quantitative trait loci (QTL) which contribute to collagen-induced arthritis, we have analyzed crosses between B10.Q and DBA/1. Gene segregation experiments using F2 intercrosses and backcrosses revealed several QTLs originating from both B10.Q and DBA/1.
| Materials and Methods |
|---|
|
|
|---|
The DBA/1 mice originated from The Jackson Laboratory, and the B10.Q mice originated from Jan Klein, Tübingen, Germany. They were bred and used in conventional animal facilities under stable infectious, light, temperature, feeding, handling, and caging conditions. Rat CII was prepared as described earlier (26). CIA was induced by intradermal immunization in the base of the tail with 50100 µg CII emulsified in CFA (Difco, Detroit, MI) as described earlier (16). The mice were 810 wk old at the time of immunization, and clinical scoring of arthritis commenced 14 days after immunization.
The clinical severity of arthritis was scored according to a graded scale: 1 point = swelling and erythema in a single joint; 2 points = swelling and erythema in more than 1 joint; and 3 points = severe arthritis of the entire paw. Each mouse could thus obtain a maximal score of 12. The severity trait is the maximal score observed in each individual mouse. The onset trait is the logarithmic value of the onset score excluding unaffected animals. For the calculation of logarithm of odds (LOD) scores, we transformed the onset day values into "onset score" by a two-step calculation to adjust for interexperimental variation, because the F2 intercross experiments were performed as three different experiments although with identical setup. First, the earliest day of observed onset in each experiment was given a score of 35 and the latest day of observed onset was given a score of 0. An adjustment factor for each experiment was calculated by: 35/(day after last observed onset day in the experiment - earliest observed onset day in the same experiment). Secondly, the onset score for every observed onset day in each experiment was calculated by: adjustment factor x (day after last observed onset day - the observed onset day).
In comparison with using only onset score values, the log onset values exclude the influence by the incidence trait and are closer to normal distribution and partly remove epistatic influence (27).
Genotyping
Tail tips were used for preparation of genomic DNA according to
a standard protocol (28). PCR was performed in 200 µM
dNTP, 1.5 mM MgCl, 20 mM Tris-HCI with pH 8.3, 0.5 µM concentrations
of forward and reverse primer (Research Genetics, Huntsville, AL), 0.5
U Taq DNA polymerase (Perkin-Elmer, Norwalk, CT), and 20 ng
genomic DNA in a final volume of 10 µl. The forward primer was
phosphorylated with 0.4 µCi [32
-P]ATP
(3000 Ci/mmol, DuPont, Wilmington, DE) as described before.
Amplification conditions were as follows: 94°C for 3 min, followed by
25 cycles of 94°C for 15 s, 55°C for 1 min, 72°C for 1 min
30 s, and a final extension at 72°C for 7 min. The PCR was done
in a BioOven (Bio Therm, San Francisco, CA) and/or a MJR PTC-225
thermal cycler (Watertown, MA). The PCR products were size fractionated
on 6% polyacrylamide gels (AT-Biochem, Malvern, PA). The gels were
either exposed for 1218 h on Hyperfilm (Amersham, Evanston, IL) or
analyzed in a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). All
markers were scored either on the film or by a PhosphorImager computer
screen by two independent readers.
Linkage analysis
All linkage analyses have been made with the MAPMAKER computer
package (29). Order of loci was obtained from the
Massachusetts Institute of Technology (Cambridge, MA) database
(30) and the Mouse Genome Informatics database.
Association of individual markers with phenotypes was established by
the use of
2 statistics, assigning animals to
the affected and unaffected groups and comparing the genotypes of
affected and unaffected animals. Log likelihood of linkage was
calculated with MAPMAKER/QTL by using the semiquantitative disease
severity trait as well as the semiquantitative disease onset trait
(29, 31, 32). As significance and suggestive linkage
threshold values, we have followed the guidelines suggested by Lander
and Kruglyak (33).
| Results |
|---|
|
|
|---|
The highly susceptible parental strain DBA/1 develops 90100%
arthritis in males and 60100% arthritis in females, whereas the less
susceptible strain B10.Q develops arthritis in 2050% of males and
030% of females (Table I
). The high
variability between different experiments is the result of
environmental factors some of which are known such as hormone cycling,
light, and stress (15, 24, 34, 35). These factors also
influence the observed sex difference; male mice are more susceptible
than females. The (B10.Q x DBA/1)F1 mice
are highly susceptible, indicating the presence of dominant genes.
|
|
After screening of parental DNA with 700 mouse microsatellites, we selected 170 informative markers covering the genome. In total, 55% of the markers were informative, indicating a significant evolutionary distance between the strains. The selected 170 informative markers gave an 84% coverage based on 10-cM distances and more than 95% coverage based on 20-cM distances. The maximum intermarker distance was 29.9 cM. Our mapping strategy was a 2-step approach: 1) the 92 most severely affected animals were genotyped; and 2) the remaining mice were typed for markers from all regions, showing suggestive linkage. The accuracy of our loci order and interval maps was verified by comparing the genetic map calculated from our data with the published Massachusetts Institute of Technology map and Mouse Genome Informatics map. A few differences between our map and the published maps were found. These differences were corrected before performing Mapmaker/QTL based calculations.
Four QTLs were found in the initial screen, located on chromosomes 6,
7, 8, and 10 (Tables
II, Fig. 2
). The locus found on chromosome 6
(linked to the markers D6 Mit19) gave the highest LOD score of 4.7 with
the arthritis onset trait, which explained
16% of the genetic
variance. Two peaks could be identified in the LOD score curve (Fig. 2
), which may indicate the presence of more than one susceptibility
gene although they could not be fully separated. Interestingly, these
two peaks on chromosome 6 were related to the gender of the mice (Fig. 3
). The incidence trait, analyzed with
the nonparametric
2 test, gave a suggestive
2 value of 10.42 with 2 df
(p = 0.0055), and the severity trait was not or
only very weakly associated (LOD score, 1.5). Taken together, these
data suggest that this genetic region contains QTLs that control the
disease onset rather than severity. Surprisingly, the disease-promoting
allele was dominantly inherited from the B10.Q strain, because a
delayed onset of disease was associated with the DBA/1 allele in a
recessive manner.
|
|
Analysis of F2 backcross mice
To confirm linkage, we backcrossed F1 mice
to the resistant strain B10Q. Of 86 analyzed (F1
xB10.Q)F2 backcross mice, 45 (52%) developed arthritis
(Table I
). The linkage on chromosome 6 was reproduced in the backcross
with the same inheritance pattern and within the same chromosomal
region. However, in the backcross experiment, the most significant
association was with the D6 MIT188 marker rather than the closely
located D6 MIT19 marker that revealed highest LOD score in the
intercross experiment, again indicating the possible presence of
several loci in this region. The highest LOD score in the backcross
experiment was Z = 2.7 (Z was calculated by
a nonparametric approach) for the onset trait, and the
2 test value was 8.01
(p = 0.0047, Table II
). However, other loci
identified in the intercross could not be significantly reproduced,
although a trend was noted with the same markers and with the same
inheritance pattern as in the intercross experiment. This was not an
unexpected outcome, because these loci should increase susceptibility
rather than suppress it, a direction that seem to be more sensitive to
genetic interactions.
|
To further isolate the chromosome 6 locus on the B10.Q background,
F2 backcross mice that were
heterozygous for relevant markers on chromosome 6 were mated with B10.Q
mice. Of the resulting 132 offspring in the N3 generation of
backcrossed mice, 59 (45%) developed arthritis. The N3 backcross mice
were genotyped with the same markers on chromosome 6 as earlier used,
and the locus could be reproduced (Z = 2.5 with marker
D6 mit124) for the onset trait and with a significant
2 test value (p =
0.0092) (Table II
).
Comparison with homologous regions in the rat
Because several highly significant loci associated with CIA in the
rat has been identified, we compared the homologous regions in the rat
with our mouse loci. Strikingly, most of the major non-MHC rat loci
could be reproduced in our cross (Fig. 4
); Cia2 on rat chromosome 1
is homologous with Cia7 on mouse chromosome 7,
Cia3 on rat chromosome 4 is homologous with Cia6
on mouse chromosome 6, and Cia4 on rat chromosome 7 is
homologous with Cia8 on mouse chromosome 10.
|
| Discussion |
|---|
|
|
|---|
Surprisingly, we were unable to identify significant loci in the B10.Q x DBA/1 cross that could explain the higher susceptibility to CIA of the DBA/1 mouse. Suggestive linkages were found on chromosomes 7, 8, and 10, and these could at least partly explain the higher susceptibility of the DBA/1 mouse. The effects of these loci were seen on the incidence and severity of arthritis rather than on disease onset. Most likely, additional minor loci are present but were impossible to detect in our experiment. Part of the difficulties in reaching significance and thus in detecting additional loci may be the result of the high influence by environmental factors on the strains used in our cross, and possibly also stochastic events, leading to low penetrance and high variability of disease expression. For example, the DBA/1 mice spontaneously develop arthritis if they are stressed, an influence that may also enhance the development of CIA (16). In addition, the DBA/1 mouse is prone to effects by many other variable factors such as sex hormones and light (35, 38). Thus, the development of CIA in DBA/1 mice is influenced by a number of environmental factors, as for RA.
A comparison with previously identified loci that have been associated
with autoimmune disease models revealed some striking homologies,
especially with arthritis models (Fig. 4
). The Cia6 locus on
chromosome 6 is homologous with a region on rat chromosome 4 that
harbors susceptibility loci for CIA (Cia3) (9),
mycobacteria-induced arthritis (Aia3) (10), and
pristane-induced arthritis (Pia5 and Pia35)
(12). The homologous region in the rat in fact contain two
separate QTL controlling pristane-induced arthritis (Pia5
and Pia2) located approximately at the same positions as the
two linkage peak in the chromosome 6 region in the mouse
(12). In addition, this region appears to contain rat loci
associated with lymphopenia (lyp1), diabetes
(Idd1) (39), and thyroiditis (40).
In the mouse, loci associated with diabetes (Idd6)
(41, 42) and lupus (Lbw4) (43)
have been identified on chromosome 6 although these are more distally
located. Taken together, this chromosomal region most likely contains
one or several genes of general importance for autoimmune disease. The
region contains several interesting candidate genes such as the
Igk gene family (Ig
chain family), IL12a, IL7r,
IL5a, and Tcrb gene families (TCR-ß).
The suggestive locus on chromosome 10 (Cia8) is homologous with a region on rat chromosome 7 containing the Cia4 locus associated with CIA in the rat. The region contains several collagen genes such as Col10a1, Col8a1, Col6a1, and Col6a2 (procollagen type gene families). The suggestive locus on chromosome 7 (Cia7) is located in a region homologous with a region on rat chromosome 1 that contains the Cia2 locus as well as candidate genes such as IL4ra and the mouse homologue of rat rt6.
The presently identified loci, together with the previously isolated Cia1 and Cia5 associated with mouse CIA, correspond to most thus far identified loci in the rat that show significant linkage with CIA (Cia17) (9, 44), suggesting a striking similarity in the genetic control of the disease in both species. Interestingly, in both species, the disease was induced with heterologous type II collagen producing a disease with a more self-limited disease course than the disease induced with homologous CII. However, the finding that at least two of the loci (Cia1 and Cia5) were detected in another more chronic arthritis model, the pristane-induced arthritis (12), indicates that the responsible genes may have general importance for the development of arthritis.
The mouse is a preferred species for the further work to isolate the genes responsible for CIA not only by providing a more economical approach for the production of congenic strains but also by offering the possibilities of using embryonic stem cell techniques. A parallel identification of the genes in mice and rats will provide the best information for further understanding of the basic mechanisms behind autoimmune arthritis and should also ultimately allow the identification of polymorphic genes in humans of importance for RA.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprints requests to Dr. Rikard Holmdahl, Section for Medical Inflammation Research, CMB, Lund University, Box 94, S-22362 Lund, Sweden. E-mail address: ![]()
3 Abbreviations used in the paper: RA, rheumatoid arthritis; CIA, collagen-induced arthritis; CII, type II collagen; QTL, quantitative trait locus; LOD, logarithm of odds. ![]()
Received for publication January 11, 1999. Accepted for publication June 14, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
X. Yu, H. Teng, A. Marques, F. Ashgari, and S. M. Ibrahim High Resolution Mapping of Cia3: A Common Arthritis Quantitative Trait Loci in Different Species J. Immunol., March 1, 2009; 182(5): 3016 - 3023. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ahlqvist, R. Bockermann, and R. Holmdahl Fragmentation of Two Quantitative Trait Loci Controlling Collagen-Induced Arthritis Reveals a New Set of Interacting Subloci J. Immunol., March 1, 2007; 178(5): 3084 - 3090. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yu, K. Bauer, P. Wernhoff, D. Koczan, S. Moller, H.-J. Thiesen, and S. M. Ibrahim Fine Mapping of Collagen-Induced Arthritis Quantitative Trait Loci in an Advanced Intercross Line J. Immunol., November 15, 2006; 177(10): 7042 - 7049. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohmura, A. Johnsen, A. Ortiz-Lopez, P. Desany, M. Roy, W. Besse, J. Rogus, M. Bogue, A. Puech, M. Lathrop, et al. Variation in IL-1{beta} gene expression is a major determinant of genetic differences in arthritis aggressivity in mice PNAS, August 30, 2005; 102(35): 12489 - 12494. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Loughry, S. Fairchild, N. Athanasou, J. Edwards, and F. C. Hall Inflammatory arthritis and dermatitis in thymectomized, CD25+ cell-depleted adult mice Rheumatology, March 1, 2005; 44(3): 299 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Backlund, K. S. Nandakumar, R. Bockermann, L. Mori, and R. Holmdahl Genetic Control of Tolerance to Type II Collagen and Development of Arthritis in an Autologous Collagen-Induced Arthritis Model J. Immunol., October 1, 2003; 171(7): 3493 - 3499. [Abstract] [Full Text] [PDF] |
||||
![]() |
A B Blom, P L E M van Lent, A E M Holthuysen, C Jacobs, and W B van den Berg Skewed balance in basal expression and regulation of activating v inhibitory Fc{gamma} receptors in macrophages of collagen induced arthritis sensitive mice Ann Rheum Dis, May 1, 2003; 62(5): 465 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Adarichev, J. C. Valdez, T. Bardos, A. Finnegan, K. Mikecz, and T. T. Glant Combined Autoimmune Models of Arthritis Reveal Shared and Independent Qualitative (Binary) and Quantitative Trait Loci J. Immunol., March 1, 2003; 170(5): 2283 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jirholt, A.-K. Lindqvist, J. Karlsson, A. Andersson, and R. Holmdahl Identification of susceptibility genes for experimental autoimmune encephalomyelitis that overcome the effect of protective alleles at the eae2 locus Int. Immunol., January 1, 2002; 14(1): 79 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. M. Johansson, A.-S. Hansson, K. S. Nandakumar, J. Backlund, and R. Holmdahl IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies J. Immunol., September 15, 2001; 167(6): 3505 - 3512. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barton, S. Eyre, A. Myerscough, B. Brintnell, D. Ward, W.E.R. Ollier, J.C. Lorentzen, L. Klareskog, A. Silman, S. John, et al. High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis Hum. Mol. Genet., September 1, 2001; 10(18): 1901 - 1906. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Merriman, H. J. Cordell, I. A. Eaves, P. A. Danoy, F. Coraddu, R. Barber, F. Cucca, S. Broadley, S. Sawcer, A. Compston, et al. Suggestive Evidence for Association of Human Chromosome 18q12-q21 and Its Orthologue on Rat and Mouse Chromosome 18 With Several Autoimmune Diseases Diabetes, January 1, 2001; 50(1): 184 - 194. [Abstract] [Full Text] |
||||
![]() |
J. M. Otto, R. Chandrasekeran, C. Vermes, K. Mikecz, A. Finnegan, S. E. Rickert, J. T. Enders, and T. T. Glant A Genome Scan Using a Novel Genetic Cross Identifies New Susceptibility Loci and Traits in a Mouse Model of Rheumatoid Arthritis J. Immunol., November 1, 2000; 165(9): 5278 - 5286. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |